
Cardiovascular Study Hawke's Bay 79
Hawke's Bay
Please note that this study has now closed. However, we encourage you to pre-register your interest for future cardiovascular studies here.
Description
What to expect
Ages
18 years or older
Duration
Up to 4.5 years and includes approximately 13–15 scheduled clinic visits over the course of the study along with additional safety check-ins.
Compensation
Participants will be compensated up to $1,875
Eligibility Criteria
You may qualify for this study if you:
OR
Other eligibility criteria will apply.
Locations
Atherosclerotic cardiovascular disease (ASCVD) is a chronic, life-threatening condition caused by the build-up of plaque in the arteries, leading to reduced blood flow. This can result in heart attacks, strokes, and poor circulation—often with lasting consequences.
Even with today’s treatments, such as statins and other cholesterol-lowering medications, many people still have high levels of LD (“bad”) cholesterol, putting them at continued risk of serious cardiovascular events.
Living with ASCVD can mean ongoing medical care, limited physical activity, and an increased risk of unexpected health emergencies. For those who have already experienced a heart attack, stroke, or related surgery—or who are considered high risk—proactive management is essential.
This study is evaluating an investigational medication that may further lower LDL Cholesterol and help reduce the risk of future cardiovascular events when taken alongside your current cholesterol-lowering therapy.
Researchers hope this medication will offer an additional layer of protection beyond what current treatments provide.
By taking part, you’ll be helping to advance scientific understanding and contribute to research that could improve outcomes for millions of people with or at risk for cardiovascular disease.
If you qualify and choose to participate, you’ll be randomly assigned to receive either the investigational medication or a placebo (an inactive tablet)—taken once daily alongside your current cholesterol-lowering medications.
Throughout the study, you’ll attend scheduled clinic visits where our experienced team will monitor your heart health and general wellbeing.
These visits will include:
Our clinical team will closely track your safety and progress every step of the way.
Why Participate?
Register your interest now and find out if participating in this study is right for you.
Your privacy is important to us—any information you share will be kept strictly confidential.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future cardiovascular studies here.